Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADAR: Early Adalimumab in Early Rheumatoid Arthritis
NCT01162421Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2010
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
01
Overview
Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) comparing Early Adalimumab with Standard of Care (2 arms). Primary endpoint: Percentage of Participants With No Radiographic Progression at 12 months. Started Sep 2010; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01162421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01162421.